You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CNTY-101

Showing 1 - 25 of 671
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

R/R CD19-Positive B-Cell Malignancies, Indolent Non-Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma Trial (CNTY-101, IL-2,

Recruiting
  • R/R CD19-Positive B-Cell Malignancies
  • +2 more
  • CNTY-101
  • +2 more
  • Detroit, Michigan
  • +1 more
Dec 21, 2022

Chronic Hepatitis b Trial in Auckland (AB-101, Placebo, Nucleos(t)ide Analogue)

Not yet recruiting
  • Chronic Hepatitis b
  • Auckland, New Zealand
    New Zealand Clinical Research Auckland
Jul 26, 2023

Nasopharyngeal Carcinoma Trial in Wuhan (KSD-101)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • KSD-101
  • Wuhan, China
    Tongji Hospital, Tongji Medical College, Huazhong University of
Oct 19, 2023

Solid Tumor Trial in China (BPB-101)

Not yet recruiting
  • Solid Tumor
  • Guangzhou, Guangdong, China
  • +3 more
May 11, 2023

Frontotemporal Dementia, FTD, FTD-GRN Trial in Poland, Spain (Intrathalamic AAV.PGRN administration, Intrathalamic AVB-101)

Recruiting
  • Frontotemporal Dementia
  • +3 more
  • Intrathalamic AAV.PGRN administration
  • Intrathalamic AVB-101
  • Katowice, Poland
  • +3 more
Oct 6, 2023

Nonalcoholic Fatty Liver Disease Trial in Jerusalem (Anti-human CCL24 mAb (CM-101) - Part One, Anti-human CCL24 mAb (CM-101) -

Completed
  • Nonalcoholic Fatty Liver Disease
  • Anti-human CCL24 monoclonal antibody (CM-101) - Part One
  • +3 more
  • Jerusalem, Israel
    Hadassah University Hospital - Ein Kerem
Sep 13, 2023

Cancer Trial (Antibody-Drug Conjugate)

Not yet recruiting
  • Cancer
  • Antibody-Drug Conjugate
  • (no location specified)
Aug 23, 2023

Community-acquired Pneumonia, Bacterial Pneumonia Trial in Cincinnati (CMTX-101, Placebo)

Recruiting
  • Community-acquired Pneumonia
  • Bacterial Pneumonia
  • Cincinnati, Ohio
    Medpace Clinical Pharmacology Unit
Jan 20, 2023

Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa, RDEB Trial in Redwood City, Worcester (EB-101 Surgical

Not yet recruiting
  • Epidermolysis Bullosa
  • +2 more
  • EB-101 Surgical application of RDEB wounds
  • Redwood City, California
  • +1 more
Feb 13, 2023

NSCLC, HNSCC, Melanoma Trial (CJRB-101, Pembrolizumab injection)

Not yet recruiting
  • NSCLC
  • +5 more
  • (no location specified)
Jun 1, 2023

Idiopathic Inflammatory Myopathies, Diffuse Cutaneous Systemic Sclerosis, SLE Nephritis Trial (KYV-101, Cyclophosphamide,

Not yet recruiting
  • Idiopathic Inflammatory Myopathies
  • +3 more
  • (no location specified)
Nov 21, 2023

Orthostatic Hypotension Trial in Newcastle Upon Tyne (ISO-101)

Not yet recruiting
  • Orthostatic Hypotension
  • ISO-101
  • Newcastle Upon Tyne, United Kingdom
    Falls and Syncope Service, Older People's Medicine, The Newcastl
Sep 8, 2023

Oropharyngeal Squamous Cell Carcinoma Trial in Saint Louis (CUE-101)

Recruiting
  • Oropharyngeal Squamous Cell Carcinoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 22, 2022

Pulmonary Arterial Hypertension Trial in Indianapolis (AV-101)

Recruiting
  • Pulmonary Arterial Hypertension
  • Indianapolis, Indiana
    Indiana University Health
Dec 6, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Atezolizumab
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 6, 2023

HIV-1-infection Trial in San Francisco, Saint Louis, Camden (EBT-101)

Enrolling by invitation
  • HIV-1-infection
  • EBT-101
  • San Francisco, California
  • +2 more
Oct 17, 2022

Age-Related Macular Degeneration Trial in Sydney, Melbourne, Tel Aviv (VOY-101)

Recruiting
  • Age-Related Macular Degeneration
  • VOY-101
  • Sydney, New South Wales, Australia
  • +3 more
Oct 17, 2023

Alpha 1-Antitrypsin Deficiency, Emphysema Trial (INBRX-101)

Not yet recruiting
  • Alpha 1-Antitrypsin Deficiency
  • Emphysema
  • (no location specified)
May 31, 2023

Glucocorticoids Toxicity, COVID-19, Infectious Disease Trial in Bangalore (101-PGC-005)

Active, not recruiting
  • Glucocorticoids Toxicity
  • +3 more
  • Bangalore, Karnataka, India
    ICBio Clinical Research Pvt. Ltd.
Dec 13, 2022

Celiac Disease, Coeliac Disease Trial (KAN-101, Placebo)

Not yet recruiting
  • Celiac Disease
  • Coeliac Disease
  • (no location specified)
Aug 14, 2023

QT/QTc Trial in Austin (Ecopipam Hydrochloride, Moxifloxacin, Placebo)

Recruiting
  • QT/QTc
  • Ecopipam Hydrochloride
  • +2 more
  • Austin, Texas
    PPD Austin Phase 1 Clinical Research Unit
Apr 21, 2023

Alpha 1-Antitrypsin Deficiency, Emphysema Trial in Australia, United States (INBRX-101, Zemaira)

Recruiting
  • Alpha 1-Antitrypsin Deficiency
  • Emphysema
  • Birmingham, Alabama
  • +25 more
May 11, 2023

Pancreatic Cancer Trial in Aurora (TTI-101)

Not yet recruiting
  • Pancreatic Cancer
  • Aurora, Colorado
    University of Colorado
Nov 30, 2023

Healthy Volunteers Trial in Cincinnati (VEL-101, Placebo)

Recruiting
  • Healthy Volunteers
  • Cincinnati, Ohio
    CTI Clinical Research Center
Nov 1, 2022

Healthy Trial in London (UPB-101)

Active, not recruiting
  • Healthy
  • London, United Kingdom
    Richmond Pharmacology
Jan 19, 2023